Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity, Geospiza Integrate Software for Next-Gen Sequencing Data

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ingenuity Systems today said it and Geospiza will integrate their software products in a collaboration that will allow researchers to gain "deep biological insights from their project samples."

Under the deal, Ingenuity will integrate its IPA software with Geospiza's GeneSifter to create a "rapid and reliable" workflow for the analysis and visualization of next-generation sequencing data, the Redwood City, Calif.-based company said.

Terms of the deal were not disclosed.

In a statement, Todd Smith, Chief Technology Officer for Geospiza said, "Our integration with IPA will accelerate drug discovery and 'omics research pipelines by enabling NGS researchers to understand and visualize their data in the context of known biological processes, functions, diseases, pathways and relationships, through IPA's powerful analysis capabilities and the timely, detailed information in the Ingenuity Knowledge Base."

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.